improving Oncology investigation with built-in KRAS Assay expert services and RAS Assays
In the promptly evolving subject of oncology research, accurate and efficient mutation screening is crucial for acquiring targeted therapies. The KRAS expert services Platform plays a pivotal purpose With this landscape by providing in depth solutions for KRAS mutation profiling and Evaluation. KRAS mutations, present in somewhere around 95% of RAS